Boardroom Media (CFO News)
At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top China based CFO’ operating in the Health Care space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected]
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Billy Cho
Chief Financial Officer of Zai Lab
Billy Cho is our chief financial officer since March 2018. Prior to joining Zai Lab, Billy Cho was the Managing Director and Head of Asia Healthcare Investment Banking at Citigroup. Based in Hong Kong since 2011, Billy Cho was responsible for healthcare client coverage at Citigroup across the Asia Pacific region and led many important biopharma transactions in China including ZaiLab’s US IPO. Prior to this, he was based in New York in healthcare M&A investment banking and also spent time in corporate development for a pharmaceutical services company. Billy Cho started his career at Ernst & Young performing financial audits of US-based healthcare companies. Billy Cho earned his M.B.A. from the Wharton School of the University of Pennsylvania and M.A. in Accounting from University of Virginia.
Follow Billy Cho:
About Zai Lab: Zai Lab brings transformative medicines for cancer, autoimmune, and infectious diseases to patients in China and around the world.
Zidong Zhang
Chief Financial Officer of Shanghai Henlius Biotech
The company Chief Financial Officer, Dr. Zidong Zhang graduated from Fudan University for BS in chemistry, then obtained Ph.D. degree from Boston University in Biochemistry and MBA from Duke University the Fuqua School of Business. Dr. Zhang had worked as Equity Analyst for UBS in New York, covering US large Cap Pharmaceuticals and Specialty Pharmaceutical sector. He had a key focus in therapeutic areas as Oncology(especially for Immuno Oncology), autoimmune diseases, and other areas as Women’s health and CNS. He also developed a specialty and in-depth knowledge in generics market entry pathway and bio-similar entry/competition. Before UBS, healso worked for Bayer in the US as an internal consultant. He had multiple projects across US, Europe, and China, including strategic planning and market forecasts for US and China, merger and acquisition, organizational structure design and implementation, etc.
Follow Zidong Zhang:
About Novotech, Shanghai Henlius Biotech: Shanghai Henlius Biotech is joint venture company that provides clinical-stage biopharmaceutical services.
Richard Yeh
Chief Financial Officer of CStone Pharmaceuticals
Follow Richard Yeh:
About CStone Pharmaceuticals: CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
Fengmao Hua
Executive Director and CFO of Viva Biotech
Fengmao Hua has approximately 20 years of experience in the investment banking industry. Fengmao Hua previously worked at a number of investment banking firms where he was mainly responsible for corporate finance, public offering, reorganization, merger and acquisitions as well as other financial consulting work. Fengmao Hua obtained his bachelor’s degree in English from Shanghai International Studies University (上海外國語大學) in the PRC , and obtained master’s degree in business administration from the International University of Japan in Japan. Fengmao Hua is a responsible officer for Type 9 regulated activities under the SFO.
Follow Fengmao Hua:
About Viva Biotech: Viva Biotech is a Healthcare Start Up Based In Shanghai.
Simon Xu
CFO of 3D Medicines
Follow Simon Xu:
About 3D Medicines: 3D Medicines mission is to improve people’s health through cancer personalized diagnostics and treatment.
Ling Lu
CFO of Laviana Pharma
Follow Ling Lu:
About Laviana Pharma: Laviana Pharmatech specializes in providing process and manufacture outsourcing services for the pharmaceutical industry.
Ce Xu
CFO of Genetron Health
Follow Ce Xu:
About Genetron Health: Genetron Health is a world-leading expert in precision medicine.
ZheYue Li
CFO of Kether
Li ZheYue currently works as the CFO for Kether. He used to serve as the Technical Service Center for Student Scientific Instruments and Technology Department of Zhejiang University.
Follow ZheYue Li:
About Kether: Kether is a designer and developer of brain monitoring device company.
Zhenshan Wu
CFO of Beijing Tiantan Biological Products
Zhenshan Wu is CFO at Beijing Tiantan Biological Products.
Follow Zhenshan Wu:
About Beijing Tiantan Biological Products: Beijing Tiantan Biological Products Corporation Limited specializes on the biopharmaceutical industry.
Max Chan
CFO of FORESEE PHARMACEUTICALS, INC.
Max Chan is a reputable corporate executive with more than 20 years of experience, including 10 years as CFO of public companies listed on NASDAQ and TPEx. Prior to joining JHL Biotech in Oct. 2015, Max Chan was CFO of TaiGen Biopharmaceuticals (TPEx: 4157.TWO) from 2010 to 2015, CFO of Himax Technologies (NASDAQ: HIMX) from 2004 to 2010, treasury manager of Intel Capital, the strategic investment division of Intel Corporation (NASDAQ: INTC) from 2000 to 2004, senior associate of Credit Suisse First Boston (NYSE: CS) in 2000, and manager at the Overseas Direct Investment Department of China Development Industry Bank (TAIEX: 2883.TW) from 1992 to 2000. Max Chan holds a B.S. degree in civil engineering and an M.B.A. degree in finance from National Taiwan University, and an M.S. degree in business administration from the University of Illinois at Urbana-Champaign.
Follow Max Chan:
About FORESEE PHARMACEUTICALS, INC.: FORESEE PHARMACEUTICALS, INC. is a pharmaceutical business located in Newark, Delaware, United States.
Fei You
Chief Financial Officer of Jinxin Fertility
Follow Fei You:
About Jinxin Fertility: Jinxin Fertility is a Chinese fertility services provider.
Delian Zhang
CFO of Laoken Medical Technology
Follow Delian Zhang:
About Laoken Medical Technology: Laoken Medical Technology is focused on the R&D and production of sterilization and disinfection products.
